Berlin is trying to stop Washington from poaching CureVac, a firm working towards a vaccine - as German politicians insist no country should have a monopoly on such a drug. German government sources said the U.S. administration was looking into how it could gain access to a potential vaccine being developed by the firm. Earlier, the Welt am Sonntag German newspaper reported that U.S. President Donald Trump had offered funds to lure CureVac to the United States, and the German government was making counter-offers to tempt it to stay. A German Economy Ministry spokeswoman also said Berlin "has a great interest" in producing vaccines in Germany and Europe. (Image: REUTERS)Florian von der Muelbe, CureVac's chief production officer and co-founder, told Reuters last week the company had started with a multitude of coronavirus vaccine candidates and was now selecting the two best to go into clinical trials.

Source: Daily Mirror March 15, 2020 15:00 UTC